Ashok Kumar Jayavelu

7PUBLICATIONS
98CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 09, 2026
BAF complex-independent gene activation by SS18::SSX.

Afroditi Sotiriou, Jinxiu Li, Sanya Middha

|Nov 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.

Ulrike Höckendorf, Sayantanee Dutta, Arnold Kloos

|Jul 15, 2025
Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma.

Bartimée Galvan, Loïc Ongena, Jonathan Bruyr

|Aug 02, 2024
The E3 ubiquitin ligase Herc1 modulates the response to nucleoside analogs in acute myeloid leukemia.

Maja Jankovic, William W L Poon, Cristobal Gonzales-Losada

|Mar 08, 2024
Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia.

Eloísa Felipe Fumero, Carolin Walter, Joris Maximillian Frenz

Pageof 2